Syngene [SYNGENE] vs Laurus Labs [LAURUSLABS] Detailed Stock Comparison

Syngene International Ltd.

NSE
Loading...

Laurus Labs Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Syngene International Ltd. wins in 12 metrics, Laurus Labs Ltd. wins in 8 metrics, with 0 ties. Syngene International Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Syngene International Ltd. Laurus Labs Ltd. Better
P/E Ratio (TTM) 48.19 70.26 Syngene International Ltd.
Price-to-Book Ratio 3.57 12.32 Syngene International Ltd.
Debt-to-Equity Ratio 12.28 44.83 Syngene International Ltd.
PEG Ratio -0.56 0.06 Laurus Labs Ltd.
EV/EBITDA 16.28 37.60 Syngene International Ltd.
Profit Margin (TTM) 9.47% 12.55% Laurus Labs Ltd.
Operating Margin (TTM) 12.94% 20.22% Laurus Labs Ltd.
EBITDA Margin (TTM) 12.94% 20.22% Laurus Labs Ltd.
Return on Equity 10.50% 7.79% Syngene International Ltd.
Return on Assets (TTM) 7.30% 3.84% Syngene International Ltd.
Free Cash Flow (TTM) $3.98B $-393.50M Syngene International Ltd.
Dividend Yield 0.39% 0.21% Syngene International Ltd.
1-Year Return -29.79% 109.17% Laurus Labs Ltd.
Price-to-Sales Ratio (TTM) 4.55 8.81 Syngene International Ltd.
Enterprise Value $151.62B $623.27B Laurus Labs Ltd.
EV/Revenue Ratio 4.08 9.27 Syngene International Ltd.
Gross Profit Margin (TTM) 74.99% 60.94% Syngene International Ltd.
Revenue per Share (TTM) $92 $125 Laurus Labs Ltd.
Earnings per Share (Diluted) $8.74 $15.60 Laurus Labs Ltd.
Beta (Stock Volatility) -0.16 0.34 Syngene International Ltd.

Syngene International Ltd. vs Laurus Labs Ltd. Stock Performance Analysis

Loading Price Chart...

SYNGENE
LAURUSLABS

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Syngene International Ltd.-1.10%0.89%-0.12%10.57%-31.32%-30.25%
Laurus Labs Ltd.-0.37%-1.11%4.95%44.58%38.23%25.10%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Syngene International Ltd.-29.79%-38.23%-19.99%131.38%186.56%186.56%
Laurus Labs Ltd.109.17%278.94%134.91%1,365.68%1,365.68%1,365.68%

Performance & Financial Health Analysis: Syngene International Ltd. vs Laurus Labs Ltd.

MetricSYNGENELAURUSLABS
Market Information
Market Cap i₹169.26B₹609.64B
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i970,2011,449,989
90 Day Avg. Volume i1,503,3231,817,191
Last Close₹453.50₹1,389.10
52 Week Range₹380.00 - ₹728.60₹641.05 - ₹1,457.00
% from 52W High-37.76%-4.66%
All-Time High₹960.60 (Dec 02, 2024)₹1,457.00 (Jun 08, 2026)
% from All-Time High-52.79%-4.66%
Growth Metrics
Quarterly Revenue Growth-0.03%0.26%
Quarterly Earnings Growth-0.89%1.73%
Financial Health
Profit Margin (TTM) i0.09%0.13%
Operating Margin (TTM) i0.13%0.20%
Return on Equity (TTM) i0.11%0.08%
Debt to Equity (MRQ) i12.2844.83
Cash & Liquidity
Book Value per Share (MRQ)₹117.84₹88.98
Cash per Share (MRQ)₹29.82₹1.18
Operating Cash Flow (TTM) i₹5.00B₹4.13B
Levered Free Cash Flow (TTM) i₹4.96B₹3.58B
Dividends
Last 12-Month Dividend Yield i0.39%0.21%
Last 12-Month Dividend i₹2.50₹2.00

Valuation & Enterprise Metrics Analysis: Syngene International Ltd. vs Laurus Labs Ltd.

MetricSYNGENE (Apr 26, 2026)LAURUSLABS (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i48.1970.26
Forward P/E i37.1258.80
PEG Ratio i-0.560.06
Price to Sales (TTM) i4.558.81
Price to Book (MRQ) i3.5712.32
Market Capitalization
Market Capitalization i₹169.26B₹609.64B
Enterprise Value i₹151.62B₹623.27B
Enterprise Value Metrics
Enterprise to Revenue i4.089.27
Enterprise to EBITDA i16.2837.60
Risk & Other Metrics
Beta i-0.160.34
Book Value per Share (MRQ) i₹117.84₹88.98

Financial Statements Comparison: Syngene International Ltd. vs Laurus Labs Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSYNGENE (2025)LAURUSLABS (2025)
Revenue/Sales i35.13B55.08B
Cost of Goods Sold i9.43B25.39B
COGS % of Revenue i26.8%46.1%
Gross Profit i25.70B29.68B
Gross Margin i73.2%53.9%
Research & Development iN/A553.00M
Operating Income (EBIT) i6.14B6.25B
Operating Margin i17.5%11.4%
EBITDA i10.96B10.64B
EBITDA Margin i31.2%19.3%
Pre-Tax Income i6.60B4.84B
Pre-Tax Income % of Revenue i18.8%8.8%
Income Tax i1.64B1.30B
Income Tax % of Revenue i4.7%2.4%
Net Income (Profit) i4.96B3.58B
Profit Margin i14.1%6.5%

Balance Sheet & Liquidity Metrics

MetricSYNGENE (2025)LAURUSLABS (2025)
Cash & Equivalents i3.67B995.40M
Total Current Assets i22.87B43.32B
Total Current Assets % of Revenue i65.1%78.7%
Total Current Liabilities i13.96B35.40B
Total Current Liabilities % of Revenue i39.8%64.3%
Long-Term Debt i4.09B7.08B
Long-Term Debt % of Revenue i11.6%12.9%
Total Shareholders Equity i47.27B46.03B
Retained Earnings i38.82B36.26B
Retained Earnings % of Revenue i110.5%65.8%
Property, Plant & Equipment i27.42B1.89B

Cash Flow Statement Comparison

MetricSYNGENE (2025)LAURUSLABS (2025)
Operating Cash Flow i5.00B4.13B
Operating Cash Flow % of Revenue i14.2%7.5%
Capital Expenditures i-7.60B-5.41B
Free Cash Flow i3.98B-393.50M
FCF Margin i11.3%-0.7%
Debt Repayment i-417.00M-3.16B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSYNGENELAURUSLABS
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i401.75M539.86M
Float Shares i159.12M362.63M
% Held by Insiders i53.09%32.06%
% Held by Institutions i37.28%34.74%
% Held by Public i9.63%33.20%

Dividend Analysis & Yield Comparison: Syngene International Ltd. vs Laurus Labs Ltd.

MetricSYNGENELAURUSLABS
Last 12-Month Dividend i₹2.50₹2.00
Last 12-Month Dividend Yield i0.39%0.21%
3-Year Avg Annual Dividend i₹1.25₹1.60
3-Year Avg Dividend Yield i0.14%0.15%
3-Year Total Dividends i₹3.75₹4.80
Ex-Dividend DateJun 27, 2025Oct 31, 2025